Hiperlactatemia en la ablacion quirurgica de la fibrilacion auricular y cirugia cardiaca. inverted question markEs un factor predictivo de morbimortalidad posoperatoria?

Autores de IIS La Fe

• Paula Carmona García

  Autor

• Fernando Hornero Sos

  Autor

• Alejandro Vázquez Sánchez

  Autor

Participantes ajenos a IIS La Fe

• Mateo E
• Errando CL
• Llagunes J
• De Andres J

Grupos

• Anestesia y Cuidados Críticos

• Regeneración y Trasplante Cardíaco

Abstract

INTRODUCTION: Increased serum lactate in postoperative cardiac surgery is very common and its pathogenesis is due to multiple factors. The elevation of serum lactate is associated with tissue hypoxia (hyperlactatemia type A) and non-hypoxic (hyperlactatemia type B) metabolic disorders. The aim of the study was to assess the evolution of postoperative lactate in surgical atrial fibrillation ablation during cardiac surgery, and to determine whether lactate levels could be predictors of morbimortality. MATERIAL AND METHODS: A case-control study was conducted on 32 patients undergoing surgical atrial fibrillation ablation and cardiac surgery (Maze group) and 32 matched patients (Control group), operated on between 2011 and 2012. An analysis was made of the levels of postoperative lactate, perioperative morbimortality and hospital length of stay. A univariate and multivariate study was performed for a composite endpoint of morbimortality, and prolonged length of stay. RESULTS: Lactate levels were significantly higher at 6, 12 and 24h in the Maze group. The univariate analysis showed that being in the Maze group (OR 3.88; 95% CI 1.3-11.1; P=.01) and an elevated lactate at 12h (OR 1.33; 95% CI 1.01-1.7; P=.04) were significant predictors of major complications, mortality, and longer hospital stays. In the multivariate analysis, surgical atrial fibrillation ablation (Maze group) was an independent predictor of major complications (OR 4.13; 95% CI 1.312.9; P=.015) for the morbimortality composite endpoint (OR 3.9; 95% CI 1.3-11.6; P=.01), and prolonged length of stay in the Intensive Care Unit (OR 5.7; 95% CI 2.01-15.7; P=.01). CONCLUSIONS: The atrial fibrillation surgical ablation may be a not-yet-described cause of type B hyperlactatemia, with serum peak values being reached between 4-24h after cardiac surgery. The predictive value of this elevation, its correlation with morbimortality, its sensitivity and specificity to discriminate the significant thresholds needs to be defined.

Keywords

• Ablacion de la fibrilacion auricular; Atrial fibrillation ablation; Cardiac surgery; Cirugia cardiaca; Complicaciones posoperatorias; Hiperlactatemia; Hyperlactatemia; Lactate; Lactato; Postoperative complications